Cart
sales@molnova.com
DL-trihexyphenidyl hydrochloride
CAS No. 58947-95-8
DL-trihexyphenidyl hydrochloride( —— )
Catalog No. M15177 CAS No. 58947-95-8
One of the centrally acting muscarinic antagonists used for treatment of parkinsonia disorders and drug-induced extrapyramidal movement disorders and as an antispasmodic.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 10MG | 29 | In Stock |
|
| 25MG | 39 | In Stock |
|
| 50MG | 60 | In Stock |
|
| 100MG | 80 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 183 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDL-trihexyphenidyl hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionOne of the centrally acting muscarinic antagonists used for treatment of parkinsonia disorders and drug-induced extrapyramidal movement disorders and as an antispasmodic.
-
DescriptionOne of the centrally acting muscarinic antagonsistused for treatment of parkinsonian disorders and drug-induced extrapyramidal movement disorders and as an antispasmodic.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
TargetAChR
-
RecptormAChR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number58947-95-8
-
Formula Weight337.93
-
Molecular FormulaC20H32ClNO
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESCl.OC(CCN1CCCCC1)(C1CCCCC1)C1=CC=CC=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Bognar IT, et al. Naunyn Schmiedebergs Arch Pharmacol. 1992 Jun;345(6):611-8.
molnova catalog
related products
-
Decamethonium bromid...
Decamethonium Bromide is a nicotinic AChR partial agonist and neuromuscular blocking agent.
-
Scopolamine HBr trih...
An alkaloid from SOLANACEAE, especially DATURA and SCOPOLIA.
-
Mepenzolate Bromide
Mepenzolate Bromide is a muscarinic antagonist used to treat gastrointestinal disorders, decreases the severity of elastase-induced airspace enlargement and respiratory dysfunction.
